Stay updated on Daratumumab for MRD Reappearance in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page.

Latest updates to the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page
- Check7 days agoChange DetectedAdded a MedlinePlus Genetics topic on multiple myeloma to expand the page's coverage of genetics-related information.SummaryDifference0.2%
- Check14 days agoChange DetectedAdded a government funding status notice and updated version to v3.2.0; removed a genetics topic (Multiple myeloma) and older v3.1.0 reference.SummaryDifference3%
- Check21 days agoChange DetectedUpdates broaden the topic to include MedlinePlus Genetics coverage on multiple myeloma, refresh contact details, and move to revision v3.1.0; older term and revision v3.0.2 are removed.SummaryDifference0.4%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedPage updated to revision v3.0.2; the MedlinePlus Genetics topic 'Multiple myeloma' has been removed, and the previous v3.0.1 note along with the Back to Top link were deleted.SummaryDifference0.4%
- Check43 days agoChange DetectedThe web page has been updated to include information on Multiple myeloma under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.4%
- Check50 days agoChange DetectedThe web page has undergone significant changes, including the addition of specific facility names and locations related to plasma cell myeloma, while removing several previous location references and related medical topics.SummaryDifference5%
Stay in the know with updates to Daratumumab for MRD Reappearance in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page.